Evidence map›Paper›PMID 41665996›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Methionine-specific nonreversible bioconjugation: Advancing precision protein modification.

Shirui Wang, Zhenguo Zhang, Raymond Tio, Bohan Li, Joycelyn Yi Xin Khoo, Teck-Peng Loh

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shirui Wang *Department of Chemistry, School of Sciences, Great Bay University, Dongguan 523000, China.ORCID 0009-0007-2157-829X
Zhenguo Zhang *Department of Chemistry, School of Sciences, Great Bay University, Dongguan 523000, China.
Raymond TioDivision of Chemistry and Biological Chemistry, School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore 637371, Singapore.ORCID 0009-0009-1926-152X
Bohan LiDivision of Chemistry and Biological Chemistry, School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore 637371, Singapore.
Joycelyn Yi Xin KhooDivision of Chemistry and Biological Chemistry, School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore 637371, Singapore.ORCID 0000-0002-1767-9326
Teck-Peng LohDepartment of Chemistry, School of Sciences, Great Bay University, Dongguan 523000, China.ORCID 0000-0002-2936-337X

Funding

Agency for Science, Technology and Research (A*STAR) M21K2c0114Agency for Science, Technology and Research (A*STAR) M22K9b0049Nanyang Technological University (NTU) Distinguished University Professor grant
6 · The paper itself

Abstract

We present a methionine-selective, nonreversible bioconjugation strategy that employs activated allylic bromides under mild, aqueous reaction conditions compatible with various peptides and proteins. Compared with conventional allylic bromides, our method improves conjugate stability and suppresses nonspecific reactivity under the examined reaction conditions. This method enables methionine-preferred labeling of peptides and proteins, and provides proof-of-concept applications in covalent inhibitor design and protein functionalization. As a complementary addition to existing methionine bioconjugation strategies, this chemistry expands the toolkit available for protein modification and chemical biology research.

Indexed as

Allyl CompoundsMethionineProteinsBromidesChemistry Techniques, SyntheticAllyl CompoundsBromidesMethionineProteinsactivated allylic bromidelate-stage modificationmethionine bioconjugationmethionine specificitymild conditions

Identifiers

PMID41665996
PMCPMC12912975

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.